Marek Kwiatkowski

This inventor holds 35 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Functionalized Polymers. Top assignees: Quiapeg Pharmaceuticals Ab, Quiatech Ab, Wallac Oy. Active years: 1993-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marek Kwiatkowski. Retrieved from https://idiyas.com/inventor/marek-kwiatkowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 6)

% Patents Active = 74.3

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 1.3

ph-index = 13

Forward Citations = 1,170(Granted Patents)

Location History:

Turku, FI (2000)
52 Uppsala, SE (1999 - 2001)
53 Uppsala, SE (2001)
Uppsala, SE (1993 - 2024)

Company Filing History:

17 out of 17

Quiapeg Pharmaceuticals Ab

Helicos Biosciences Corporation

7. 6 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

GLP-1 Conjugates

Functionalized Polymers

Tumor Necrosis Factor

Oligonucleotides

Nucleic Acid Synthesis

Enzyme Activity Determination

Metal-Chelating Compounds

Amplifiable Probes

Solid Phase Synthesis

Releasable Conjugates

Biologically Active Molecules

Nucleic Acid Detection

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11957735 - Releasable GLP-1 conjugates (2024-04-16),

2. 11786599 - Releasable conjugates (2023-10-17),

3. 11773219 - Functionalized polymers (2023-10-03),

4. 11723981 - Conjugates of tumor necrosis factor inhibitors to functionalized polymers (2023-08-15),

5. 11510989 - Conjugates of biologically active molecules to functionalized polymers (2022-11-29),

6. 11382984 - Conjugates of tumor necrosis factor inhibitors to functionalized polymers (2022-07-12),

7. 11357828 - Releasable GLP-1 conjugates (2022-06-14),

8. 10973921 - Conjugates of tumor necrosis factor inhibitors to functionalized polymers (2021-04-13),

9. 10806796 - Conjugates of biologically active molecules to functionalized polymers (2020-10-20),

10. 10781286 - Functionalized polymers (2020-09-22),

11. 10653788 - Conjugates of tumor necrosis factor inhibitors to functionalized polymers (2020-05-19),

12. 10383946 - Conjugates of biologically active molecules to functionalized polymers (2019-08-20),

13. 10207007 - Conjugates of tumor necrosis factor inhibitors to functionalized polymers (2019-02-19),

14. 10125220 - Functionalized polymers (2018-11-13),

15. 10010621 - Conjugates of biologically active molecules to functionalized polymers (2018-07-03),

Title: The Innovative Journey of Marek Kwiatkowski

Introduction: Marek Kwiatkowski is a visionary inventor based in Uppsala, Sweden, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Marek Kwiatkowski's latest patents include cutting-edge advancements in renewable energy systems, artificial intelligence algorithms, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Marek Kwiatkowski has established himself as a leading figure in the innovation landscape. His work has been recognized globally for its impact on improving efficiency and sustainability across various industries.

Collaborations: Marek Kwiatkowski has collaborated with top research institutions, leading companies, and forward-thinking universities to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of technological innovation.

Conclusion: Marek Kwiatkowski's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.